4 results
PRE 14C
BTAX
Biostax Corp.
16 Dec 22
Preliminary information
4:31pm
of common stock, each of the three notes prohibits the note holder, without the prior written consent of the Company, from selling, pledging
8-K
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
prohibits the Note holder, without the prior written consent of the Company, from selling, pledging, or otherwise transferring the Conversion Shares
- Prev
- 1
- Next